Ophthalmology conditions, page 3 of 4
20 conditions on this page, alphabetically from Neovascular inflammatory vitreoretinopathy to Retinitis pigmentosa 44. Each entry below describes the condition in full.
On this page
Neovascular inflammatory vitreoretinopathy
neovascular inflammatory vitreoretinopathy: A retinal and vitreous disease characterized by ocular inflammation, vascular dropout, large spots of hyperpigmentation, neovascularization of the peripheral and posterior retina, vitreous hemorrhage, and retinal detachment that has_material_basis_in heterozygous mutation in the CAPN5 gene on chromosome 11q13.5.
Also known as
- ADNIV
- autosomal dominant neovascular inflammatory vitreoretinopathy
- proliferative vitreoretinopathy
- Retinitis proliferans
Classification
Ontology identifier: DOID:9719 (Human Disease Ontology).
Classification path: disease of anatomical entity › nervous system disease › sensory system disease › eye disease › retinal disease.
Specialty: Ophthalmology
Broader conditions
Medical codes
- MeSH: D018630
- OMIM: 193235
- SNOMED CT: 232016005
Care at Weyland-Yutani Health System
Care for neovascular inflammatory vitreoretinopathy is coordinated through Ophthalmology. Your clinician will recommend tests and treatments based on your history and symptoms.
Treatment options
Diagnostic tests
When to seek care
Questions about neovascular inflammatory vitreoretinopathy? Call your nearest Weyland-Yutani location and ask for Ophthalmology.
Reference links
Nodular episcleritis
A scleral disease that is characterized by painful inflammation with surface nodule formation of the episcleral tissues that, importantly, spares the sclera itself and has_symptom pain, red eyes, photophobia, tearing, blurry vision, and appearance of eye surface irregularity. Nodular episcleritis is typically self-limited and may be caused by vascular congestion within the superficial episcleral plexus. This page summarizes how nodular episcleritis is classified and the care available at Weyland-Yutani Health System.
Classification
Ontology identifier: DOID:728 (Human Disease Ontology).
Classification path: disease of anatomical entity › nervous system disease › sensory system disease › eye disease › scleral disease.
Specialty: Ophthalmology
Broader conditions
Medical codes
- ICD-10-CM: H15.12
- ICD-9-CM: 379.02
- SNOMED CT: 70558001
Care at Weyland-Yutani Health System
Care for nodular episcleritis is coordinated through Ophthalmology. Your clinician will recommend tests and treatments based on your history and symptoms.
Treatment options
Diagnostic tests
When to seek care
Seek a medical evaluation if you are concerned about nodular episcleritis. Bring a list of current medications and any previous test results.
Reference links
Posterior amorphous corneal dystrophy
In clinical terms, posterior amorphous corneal dystrophy is described as follows: A stromal dystrophy that is characterized by irregular sheetlike areas of opacification with involvement of the Descemet membrane and, in some instances, alterations of the normal endothelial mosaic and that has_material_basis_in a chromosome 12q21.33 contiguous gene deletion syndrome.
Also known as
- chromosome 12q21.33 deletion syndrome
- PACD
Classification
Ontology identifier: DOID:0060452 (Human Disease Ontology).
Classification path: genetic disease › monogenic disease › autosomal genetic disease › autosomal dominant disease.
Specialty: Ophthalmology
Broader conditions
Medical codes
- ICD-10-CM: H18.5
- MeSH: C567546
- OMIM: 612868
Care at Weyland-Yutani Health System
Treatment of posterior amorphous corneal dystrophy begins with an evaluation in Ophthalmology. Follow-up visits track how you are responding to care.
Treatment options
Diagnostic tests
When to seek care
Questions about posterior amorphous corneal dystrophy? Call your nearest Weyland-Yutani location and ask for Ophthalmology.
Reference links
Posterior polymorphous corneal dystrophy 1
posterior polymorphous corneal dystrophy 1: A posterior polymorphous corneal dystrophy that has_material_basis_in autosomal dominant inheritance of mutation in the OVOL2 gene on chromosome 20p11.23.
Also known as
- CHED1
- Corneal Endothelial Dystrophy 1, Autosomal Dominant
- Maumenee Corneal Dystrophy
- PPCD1
Classification
Ontology identifier: DOID:0110855 (Human Disease Ontology).
Classification path: genetic disease › monogenic disease › autosomal genetic disease › autosomal dominant disease.
Specialty: Ophthalmology
Broader conditions
Medical codes
- ICD-10-CM: H18.50
- OMIM: 122000
Care at Weyland-Yutani Health System
Care for posterior polymorphous corneal dystrophy 1 is coordinated through Ophthalmology. Your clinician will recommend tests and treatments based on your history and symptoms.
Treatment options
Diagnostic tests
When to seek care
Seek a medical evaluation if you are concerned about posterior polymorphous corneal dystrophy 1. Bring a list of current medications and any previous test results.
Reference links
Primary angle-closure glaucoma
Overview. An angle-closure glaucoma characterized by closure of the anterior chamber angle by an intrinsic defect such that aqueous outflow is blocked and the intraocular pressure becomes inappropriately elevated leading to optic nerve damage and visual field loss. Primary angle-closure glaucoma has_symptom progressive peripheral vision loss, decreased vision, and pain, redness, and headache in acute cases. Primary angle closure glaucoma can be caused by anatomically narrow angle, defects in the trabecular meshwork, and iris abnormalities. Primary angle-closure glaucoma has a strong genetic component. Weyland-Yutani Health System offers diagnosis and ongoing care for primary angle-closure glaucoma.
Also known as
- primary Angle Closure Glaucoma
Classification
Ontology identifier: DOID:1405 (Human Disease Ontology).
Classification path: disease of anatomical entity › nervous system disease › sensory system disease › eye disease › glaucoma › angle-closure glaucoma.
Specialty: Ophthalmology
Broader conditions
More specific conditions
Medical codes
- ICD-10-CM: H40.2
- ICD-9-CM: 365.2
- SNOMED CT: 193544008
Care at Weyland-Yutani Health System
Treatment of primary angle-closure glaucoma begins with an evaluation in Ophthalmology. Follow-up visits track how you are responding to care.
Treatment options
Diagnostic tests
Related articles
When to seek care
Seek a medical evaluation if you are concerned about primary angle-closure glaucoma. Bring a list of current medications and any previous test results.
Reference links
Progressive peripheral pterygium
Overview. A conjunctival pterygium that is characterized by progressive (as opposed to quiescent) fleshy outpouching of conjunctival growth and has_symptom fleshy bumps on the surface of the eye, foreign body sensation, decreased vision, and astigmatism. Progressive peripheral pterygiums are more common in people prone to ocular surface injury, such as those living in sunny, hot, and dry climates. Progressive peripheral pterygiums progress from pinguecula. Weyland-Yutani Health System offers diagnosis and ongoing care for progressive peripheral pterygium.
Classification
Ontology identifier: DOID:13474 (Human Disease Ontology).
Classification path: disease of anatomical entity › nervous system disease › sensory system disease › eye disease › corneal disease › pterygium › conjunctival pterygium.
Specialty: Ophthalmology
Broader conditions
More specific conditions
Medical codes
- ICD-9-CM: 372.42
- SNOMED CT: 193881001
Care at Weyland-Yutani Health System
At Weyland-Yutani Health System, progressive peripheral pterygium is managed by Ophthalmology with support from imaging, laboratory and rehabilitation services where needed.
Treatment options
Diagnostic tests
Related articles
When to seek care
Seek a medical evaluation if you are concerned about progressive peripheral pterygium. Bring a list of current medications and any previous test results.
Reference links
Reis-Bucklers corneal dystrophy
In clinical terms, Reis-Bucklers corneal dystrophy is described as follows: an epithelial-stromal TGFBI dystrophy that is characterized by recurrent erosions and irregular geographic opacification located_in the cornea, proteinaceous deposits in the anterior stroma and subepithelium, and progressive early vision loss, and has_material_basis_in heterozygous mutation of transforming growth factor beta-induced gene located in chromosome 5q31.1, which encodes keratoepithelin. Abnormalities lead to increased protein deposition and disruption especially of Bowman's membrane of the cornea.
Also known as
- anterior limiting membrane dystrophy type I
- corneal dystrophy of Bowman layer type I
- geographic corneal dystrophy
- granular corneal dystrophy type III
- RBCD
Classification
Ontology identifier: DOID:0060453 (Human Disease Ontology).
Classification path: disease of anatomical entity › nervous system disease › sensory system disease › eye disease › corneal disease › corneal dystrophy › epithelial-stromal TGFBI dystrophy.
Specialty: Ophthalmology
Broader conditions
Medical codes
- MeSH: C535476
- OMIM: 608470
- SNOMED CT: 231930000
Care at Weyland-Yutani Health System
Ophthalmology specialists lead care for Reis-Bucklers corneal dystrophy. Plans are tailored to each patient and reviewed regularly.
Treatment options
Diagnostic tests
When to seek care
Questions about Reis-Bucklers corneal dystrophy? Call your nearest Weyland-Yutani location and ask for Ophthalmology.
Reference links
Retinal degeneration
In clinical terms, retinal degeneration is described as follows: A retinal disease that is characterized by deterioration of the retina caused by the progressive and eventual death of the cells of the retina.
Also known as
Classification
Ontology identifier: DOID:8466 (Human Disease Ontology).
Classification path: disease of anatomical entity › nervous system disease › sensory system disease › eye disease › retinal disease.
Specialty: Ophthalmology
Broader conditions
More specific conditions
Medical codes
- MeSH: D012162
- SNOMED CT: 95695004
Care at Weyland-Yutani Health System
Care for retinal degeneration is coordinated through Ophthalmology. Your clinician will recommend tests and treatments based on your history and symptoms.
Treatment options
Diagnostic tests
When to seek care
Seek a medical evaluation if you are concerned about retinal degeneration. Bring a list of current medications and any previous test results.
Reference links
Retinal disease
retinal disease: An eye disease that is located_in the retina.
Classification
Ontology identifier: DOID:5679 (Human Disease Ontology).
Classification path: disease of anatomical entity › nervous system disease › sensory system disease › eye disease.
Specialty: Ophthalmology
Broader conditions
More specific conditions
Medical codes
- ICD-10-CM: H35.9
- ICD-9-CM: 362.9
- MeSH: D012164
- SNOMED CT: 29555009
Care at Weyland-Yutani Health System
Treatment of retinal disease begins with an evaluation in Ophthalmology. Follow-up visits track how you are responding to care.
Treatment options
Diagnostic tests
When to seek care
If you or a family member may have retinal disease, contact your primary care provider or schedule a visit with Ophthalmology.
Reference links
Retinal macular dystrophy 2
retinal macular dystrophy 2: A retinal macular dystrophy characterized by slowly progressive ''bull's eye'' maculopathy, mild visual impairment, and central scotomata that has_material_basis_in heterozygous mutation in the PROM1 gene on chromosome 4p15.32.
Also known as
Classification
Ontology identifier: DOID:0070517 (Human Disease Ontology).
Classification path: genetic disease › monogenic disease › autosomal genetic disease › autosomal dominant disease › retinal macular dystrophy.
Specialty: Ophthalmology
Broader conditions
Medical codes
- MeSH: C562746
- OMIM: 608051
- SNOMED CT: 770594005
Care at Weyland-Yutani Health System
Care for retinal macular dystrophy 2 is coordinated through Ophthalmology. Your clinician will recommend tests and treatments based on your history and symptoms.
Treatment options
Diagnostic tests
Related articles
When to seek care
If you or a family member may have retinal macular dystrophy 2, contact your primary care provider or schedule a visit with Ophthalmology.
Reference links
Retinal vasculitis
A vasculitis that is characterized by inflammation of the vascular branches of the retinal artery and has_symptom painless decrease of visual acuity, visual floaters, dark spot in vision, decreased ability to distinguish colors, and distortion of images such as linear images. Patients with retinal vasculitis are cared for through our Ophthalmology service line.
Classification
Ontology identifier: DOID:11563 (Human Disease Ontology).
Classification path: disease of anatomical entity › cardiovascular system disease › vascular disease › retinal vascular disease.
Specialty: Ophthalmology
Broader conditions
Medical codes
- ICD-10-CM: H35.06
- ICD-9-CM: 362.18
- MeSH: D031300
- SNOMED CT: 77628002
Care at Weyland-Yutani Health System
At Weyland-Yutani Health System, retinal vasculitis is managed by Ophthalmology with support from imaging, laboratory and rehabilitation services where needed.
Treatment options
Diagnostic tests
When to seek care
Seek a medical evaluation if you are concerned about retinal vasculitis. Bring a list of current medications and any previous test results.
Reference links
Retinitis pigmentosa
In clinical terms, retinitis pigmentosa is described as follows: A retinal degeneration characterized by the gradual deterioration of the photoreceptors or the retinal pigment epithelium of the retina leading to progressive sight loss.
Also known as
- pericentral pigmentary retinopathy
Classification
Ontology identifier: DOID:10584 (Human Disease Ontology).
Classification path: disease of anatomical entity › nervous system disease › sensory system disease › eye disease › retinal disease › retinal degeneration.
Specialty: Ophthalmology
Broader conditions
More specific conditions
Medical codes
- ICD-10-CM: H35.52
- MeSH: C538365
- MeSH: D012174
- OMIM: 268000
- OMIM: PS268000
- SNOMED CT: 155113002
Care at Weyland-Yutani Health System
At Weyland-Yutani Health System, retinitis pigmentosa is managed by Ophthalmology with support from imaging, laboratory and rehabilitation services where needed.
Treatment options
Diagnostic tests
When to seek care
Seek a medical evaluation if you are concerned about retinitis pigmentosa. Bring a list of current medications and any previous test results.
Reference links
Retinitis pigmentosa 18
A retinitis pigmentosa that has_material_basis_in mutation in the PRPF3 gene on chromosome 1q21. Patients with retinitis pigmentosa 18 are cared for through our Ophthalmology service line.
Also known as
Classification
Ontology identifier: DOID:0110356 (Human Disease Ontology).
Classification path: genetic disease › monogenic disease › autosomal genetic disease › autosomal dominant disease.
Specialty: Ophthalmology
Broader conditions
Medical codes
- ICD-10-CM: H35.5
- MeSH: C563320
- OMIM: 601414
Care at Weyland-Yutani Health System
Ophthalmology specialists lead care for retinitis pigmentosa 18. Plans are tailored to each patient and reviewed regularly.
Treatment options
Diagnostic tests
When to seek care
If you or a family member may have retinitis pigmentosa 18, contact your primary care provider or schedule a visit with Ophthalmology.
Reference links
Retinitis pigmentosa 19
Overview. A retinitis pigmentosa that has_material_basis_in mutation in the ABCA4 gene on chromosome 1p22. Weyland-Yutani Health System offers diagnosis and ongoing care for retinitis pigmentosa 19.
Also known as
Classification
Ontology identifier: DOID:0110354 (Human Disease Ontology).
Classification path: genetic disease › monogenic disease › autosomal genetic disease › autosomal recessive disease.
Specialty: Ophthalmology
Broader conditions
Medical codes
- ICD-10-CM: H35.5
- MeSH: C566637
- OMIM: 601718
Care at Weyland-Yutani Health System
Care for retinitis pigmentosa 19 is coordinated through Ophthalmology. Your clinician will recommend tests and treatments based on your history and symptoms.
Treatment options
Diagnostic tests
When to seek care
If you or a family member may have retinitis pigmentosa 19, contact your primary care provider or schedule a visit with Ophthalmology.
Reference links
Retinitis pigmentosa 35
A retinitis pigmentosa that has_material_basis_in mutation in the SEMA4A gene on chromosome 1q22. Patients with retinitis pigmentosa 35 are cared for through our Ophthalmology service line.
Also known as
Classification
Ontology identifier: DOID:0110357 (Human Disease Ontology).
Classification path: genetic disease › monogenic disease › autosomal genetic disease › autosomal dominant disease.
Specialty: Ophthalmology
Broader conditions
Medical codes
- ICD-10-CM: H35.5
- MeSH: C565206
- OMIM: 610282
Care at Weyland-Yutani Health System
Ophthalmology specialists lead care for retinitis pigmentosa 35. Plans are tailored to each patient and reviewed regularly.
Treatment options
Diagnostic tests
When to seek care
Seek a medical evaluation if you are concerned about retinitis pigmentosa 35. Bring a list of current medications and any previous test results.
Reference links
Retinitis pigmentosa 36
A retinitis pigmentosa that has_material_basis_in mutation in the PRCD gene on chromosome 17q25. Patients with retinitis pigmentosa 36 are cared for through our Ophthalmology service line.
Also known as
Classification
Ontology identifier: DOID:0110405 (Human Disease Ontology).
Classification path: disease of anatomical entity › nervous system disease › sensory system disease › eye disease › retinal disease › retinal degeneration › retinitis pigmentosa.
Specialty: Ophthalmology
Broader conditions
Medical codes
- ICD-10-CM: H35.5
- MeSH: C566431
- OMIM: 610599
Care at Weyland-Yutani Health System
At Weyland-Yutani Health System, retinitis pigmentosa 36 is managed by Ophthalmology with support from imaging, laboratory and rehabilitation services where needed.
Treatment options
Diagnostic tests
When to seek care
If you or a family member may have retinitis pigmentosa 36, contact your primary care provider or schedule a visit with Ophthalmology.
Reference links
Retinitis pigmentosa 37
A retinitis pigmentosa that has_material_basis_in mutation in the NR2E3 gene on chromosome 15q23. Patients with retinitis pigmentosa 37 are cared for through our Ophthalmology service line.
Also known as
Classification
Ontology identifier: DOID:0110399 (Human Disease Ontology).
Classification path: genetic disease › monogenic disease › autosomal genetic disease › autosomal dominant disease.
Specialty: Ophthalmology
Broader conditions
Medical codes
- ICD-10-CM: H35.5
- MeSH: C567005
- OMIM: 611131
Care at Weyland-Yutani Health System
Treatment of retinitis pigmentosa 37 begins with an evaluation in Ophthalmology. Follow-up visits track how you are responding to care.
Treatment options
Diagnostic tests
Related articles
When to seek care
Seek a medical evaluation if you are concerned about retinitis pigmentosa 37. Bring a list of current medications and any previous test results.
Reference links
Retinitis pigmentosa 41
A retinitis pigmentosa that has_material_basis_in mutation in the PROM1 gene on chromosome 4p15. Our Ophthalmology team evaluates and manages retinitis pigmentosa 41.
Also known as
Classification
Ontology identifier: DOID:0110376 (Human Disease Ontology).
Classification path: genetic disease › monogenic disease › autosomal genetic disease › autosomal recessive disease.
Specialty: Ophthalmology
Broader conditions
Medical codes
- ICD-10-CM: H35.5
- MeSH: C567422
- OMIM: 612095
Care at Weyland-Yutani Health System
Care for retinitis pigmentosa 41 is coordinated through Ophthalmology. Your clinician will recommend tests and treatments based on your history and symptoms.
Treatment options
Diagnostic tests
When to seek care
Seek a medical evaluation if you are concerned about retinitis pigmentosa 41. Bring a list of current medications and any previous test results.
Reference links
Retinitis pigmentosa 42
A retinitis pigmentosa that has_material_basis_in mutation in the KLHL7 gene on chromosome 7p15.3. This page summarizes how retinitis pigmentosa 42 is classified and the care available at Weyland-Yutani Health System.
Also known as
Classification
Ontology identifier: DOID:0110386 (Human Disease Ontology).
Classification path: genetic disease › monogenic disease › autosomal genetic disease › autosomal dominant disease.
Specialty: Ophthalmology
Broader conditions
Medical codes
- ICD-10-CM: H35.5
- MeSH: C567854
- OMIM: 612943
Care at Weyland-Yutani Health System
At Weyland-Yutani Health System, retinitis pigmentosa 42 is managed by Ophthalmology with support from imaging, laboratory and rehabilitation services where needed.
Treatment options
Diagnostic tests
When to seek care
Questions about retinitis pigmentosa 42? Call your nearest Weyland-Yutani location and ask for Ophthalmology.
Reference links
Retinitis pigmentosa 44
A retinitis pigmentosa that has_material_basis_in mutation in the RGR gene on chromosome 10q23. Our Ophthalmology team evaluates and manages retinitis pigmentosa 44.
Also known as
Classification
Ontology identifier: DOID:0110394 (Human Disease Ontology).
Classification path: disease of anatomical entity › nervous system disease › sensory system disease › eye disease › retinal disease › retinal degeneration › retinitis pigmentosa.
Specialty: Ophthalmology
Broader conditions
Medical codes
- ICD-10-CM: H35.5
- OMIM: 613769
Care at Weyland-Yutani Health System
Ophthalmology specialists lead care for retinitis pigmentosa 44. Plans are tailored to each patient and reviewed regularly.
Treatment options
Diagnostic tests
When to seek care
If you or a family member may have retinitis pigmentosa 44, contact your primary care provider or schedule a visit with Ophthalmology.
Reference links